Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lichtin

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Bone Marrow Transplantation|January 7, 1998
Progressive disease after ABMT for Hodgkin's diseaseB J Bolwell, M Kalaycio, M Goormastic, et al.
Bone Marrow Transplantation|November 1, 1995
Outpatient bone marrow harvest: the Cleveland Clinic experienceB J Bolwell, W Maurer, J Anderson, et al.
Leukemia Research|September 4, 1999
A phase III comparison of high dose ARA-C (HIDAC) versus HIDAC plus mitoxantrone in the treatment of first relapsed or refractory acute myeloid leukemia Southwest Oncology Group StudyC Karanes, K J Kopecky, D R Head, et al.
Leukemia|January 11, 2014
Ruxolitinib leads to improvement of pulmonary hypertension in patients with myelofibrosisA Tabarroki, D J Lindner, V Visconte, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Bone Marrow Transplantation|January 7, 1998
Progressive disease after ABMT for Hodgkin's diseaseB J Bolwell, M Kalaycio, M Goormastic, et al.
Bone Marrow Transplantation|November 1, 1995
Outpatient bone marrow harvest: the Cleveland Clinic experienceB J Bolwell, W Maurer, J Anderson, et al.
Leukemia Research|September 4, 1999
A phase III comparison of high dose ARA-C (HIDAC) versus HIDAC plus mitoxantrone in the treatment of first relapsed or refractory acute myeloid leukemia Southwest Oncology Group StudyC Karanes, K J Kopecky, D R Head, et al.
Leukemia|January 11, 2014
Ruxolitinib leads to improvement of pulmonary hypertension in patients with myelofibrosisA Tabarroki, D J Lindner, V Visconte, et al.
Pageof 2